Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...